Geisinger
Mohamed Samour is a highly qualified medical professional and academic, currently serving as an Assistant Professor at Geisinger Commonwealth School of Medicine and a Hematology and Oncology Physician at Geisinger since August 2021. Samour also held the position of Interim Director at Geisinger Wyoming Valley Henry Cancer Center from September 2022 to December 2023. Previously, significant experience was gained as a Hematology Oncology Fellow at The National Institutes of Health from July 2018 to July 2021 and as President and CEO at 2strand Inc. from November 2017 to December 2019. Early career development included roles as a Research Scientist and Resident Physician at Cleveland Clinic from July 2015 to June 2018 and academic training as a medical student and trainee at Jordan University of Science and Technology from September 2009 to June 2015, where a Doctor of Medicine (M.D.) was obtained. Samour's research contributions include expertise in genome sequencing for diagnostic and research applications.
This person is not in any teams
This person is not in any offices
Geisinger
16 followers
Geisinger is comprised of 13 hospital campuses, two research centers, a college of medicine and a nearly 600,000-member health plan serving more than three million residents in central, south-central and northeast Pennsylvania and beyond. We have approximately 26,500 employees, including over 1,700 employed physicians, all of whom share a commitment to quality healthcare.